A2ARs Receptor Agonist Combo May be Synergistic in Clear Cell RCC
Clear cell renal cell carcinoma is driven by a metabolic switch that decreases VHL and increases ATP, according to an expert from Vanderbilt University Medical Center.
Immune Checkpoint Inhibition in Lung Cancer: The Good, the Bad, and the Ugly
Immune checkpoint inhibitors are a reality for the treatment of patients with NSCLC, and if approved for SCLC, would be a treatment breakthrough we have not seen for decades.
2 Clarke Drive Cranbury, NJ 08512